Solid Tumors
A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab (MK3475-587)
- Details
ClinicalTrials.gov ID:
NCT03486873
Diagnosis Type:
NA
USOR Number:
- Address
,
P: